Ken Griffin
LUNG icon

Ken Griffin’s Pulmonx LUNG Stock Holding History

Ken Griffin’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.5K Buy
57,009
+11,752
+26% +$19.4K ﹤0.01% 12223
2025
Q4 		$100K Sell
45,257
-171,919
-79% -$323K ﹤0.01% 11644
2025
Q3 		$352K Buy
217,176
+147,904
+214% +$309K ﹤0.01% 9987
2025
Q2 		$179K Sell
69,272
-114,334
-62% -$451K ﹤0.01% 10782
2025
Q1 		$1.24M Buy
183,606
+82,153
+81% +$582K ﹤0.01% 6497
2024
Q4 		$689K Buy
101,453
+99,154
+4,313% +$653K ﹤0.01% 7869
2024
Q3 		$19.1K Sell
2,299
-147,911
-98% -$1.07M ﹤0.01% 12808
2024
Q2 		$952K Buy
150,210
+16,947
+13% +$130K ﹤0.01% 6683
2024
Q1 		$1.24M Buy
133,263
+78,332
+143% +$918K ﹤0.01% 6499
2023
Q4 		$700K Buy
54,931
+51,377
+1,446% +$535K ﹤0.01% 7397
2023
Q3 		$36.7K Sell
3,554
-6,452
-64% -$74.7K ﹤0.01% 12099
2023
Q2 		$131K Sell
10,006
-153,623
-94% -$1.88M ﹤0.01% 10523
2023
Q1 		$1.83M Buy
163,629
+92,810
+131% +$916K ﹤0.01% 5558
2022
Q4 		$597K Sell
70,819
-71,459
-50% -$680K ﹤0.01% 7869
2022
Q3 		$2.37M Sell
142,278
-121,193
-46% -$2.23M ﹤0.01% 5265
2022
Q2 		$3.88M Buy
263,471
+85,518
+48% +$1.76M ﹤0.01% 4269
2022
Q1 		$4.42M Buy
177,953
+82,432
+86% +$2.13M ﹤0.01% 4423
2021
Q4 		$3.06M Sell
95,521
-350,290
-79% -$12.8M ﹤0.01% 5292
2021
Q3 		$16M Buy
445,811
+178,267
+67% +$7.01M ﹤0.01% 2327
2021
Q2 		$11.8M Buy
267,544
+89,558
+50% +$3.9M ﹤0.01% 2821
2021
Q1 		$8.14M Buy
177,986
+48,241
+37% +$2.77M ﹤0.01% 3298
2020
Q4 		$8.96M Buy
+129,745
New +$6.35M ﹤0.01% 2797

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ken Griffin's LUNG Position: Q1 2026 in Review

Ken Griffin increased its Pulmonx (LUNG) stake by 26% in Q1 2026, buying an estimated $19.4K and bringing the position to 57,009 shares worth $73.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12223.

Ken Griffin first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $16M in Q3 2021. 114 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Ken Griffin held 57,009 shares of Pulmonx worth $73.5K as of Q1 2026.
  • Ken Griffin bought 11,752 Pulmonx shares in Q1 2026, an estimated $19.4K.
  • Pulmonx made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12223 holding.
  • Ken Griffin first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • Ken Griffin's Pulmonx position peaked at $16M in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.